Marie José Kersten
Dutch Cancer Society(NL)Amsterdam Neuroscience(NL)Lymphoma Research Foundation(US)Lymphoma Study Association(FR)Amsterdam University Medical Centers(NL)Amsterdam University Medical Centers(NL)University Hospital Ulm(DE)International Myeloma Foundation(US)Cancer Center Amsterdam(NL)Vrije Universiteit Amsterdam(NL)University of Amsterdam(NL)Amsterdam UMC Location Vrije Universiteit Amsterdam(NL)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, Multiple Myeloma Research and Treatments, Viral-associated cancers and disorders
Most-Cited Works
- → KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma(2020)1,759 cited
- → Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma(2021)1,430 cited
- → Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial(2012)821 cited
- → Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs(2016)595 cited
- → Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study(2021)537 cited
- → Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma(2021)500 cited